Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study-Reference-Cited by-同舟云学术

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study

Published:2017-08-08 Issue:1 Volume:17 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Honda Yasushi,Kessoku Takaomi,Sumida Yoshio,Kobayashi Takashi,Kato Takayuki,Ogawa Yuji,Tomeno Wataru,Imajo Kento,Fujita Koji,Yoneda Masato,Kataoka Koshi,Taguri Masataka,Yamanaka Takeharu,Seko Yuya,Tanaka Saiyu,Saito Satoru,Ono Masafumi,Oeda Satoshi,Eguchi Yuichiro,Aoi Wataru,Sato Kenji,Itoh Yoshito,Nakajima Atsushi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12876-017-0652-3.pdf

Reference29 articles.

1. Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut. 2002;50:585–8.

2. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008;28:339–50.

3. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003;37:1202–19.

4. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–23.

5. Yilmaz Y, Younossi ZM. Obesity-associated nonalcoholic fatty liver disease. Clin Liver Dis. 2014;18:19–31.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer’s Disease: The Potential Role of a Novel Nano-Compound—The Transdermal Glutathione–Cyclodextrin Complex;Antioxidants;2024-09-12

3. Discovery of genomic loci for liver health and steatosis reveals overlap with glutathione redox genetics;Redox Biology;2024-09

4. Clinical characteristics and prognosis of liver injury induced by immune checkpoint inhibitors in patients with malignancies: A real‐world retrospective study;British Journal of Clinical Pharmacology;2024-07-23

5. A Narrative Review of Oxidative Stress and Liver Disease in Pregnancy: The Role of Antioxidants;Cureus;2024-07-17